Anti-CDV H/Hemagglutinin glycoprotein Polyclonal Antibody from ProteoGenix; catalogue ARO-A22533; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-CDV H/Hemagglutinin glycoprotein Polyclonal Antibody – a powerful tool for your biotech research needs.
This highly specific antibody is designed to target the Hemagglutinin glycoprotein of Canine Distemper Virus (CDV), a highly contagious and potentially fatal disease in dogs. With its superior binding affinity and sensitivity, our Anti-CDV H/Hemagglutinin glycoprotein Polyclonal Antibody is an essential tool for studying the pathogenesis and progression of CDV.
The Hemagglutinin glycoprotein is a key component of CDV, responsible for the virus’ ability to attach and enter host cells. By targeting this specific protein, our antibody effectively blocks the entry of CDV into cells, preventing viral replication and spread.
Our Anti-CDV H/Hemagglutinin glycoprotein Polyclonal Antibody is ideal for a wide range of applications in biotech research, including:
1. Virus detection and quantification – The antibody’s high sensitivity allows for accurate and reliable detection and quantification of CDV in samples.
2. Pathogenesis studies – By blocking the entry of CDV, our antibody can help researchers understand the role of the Hemagglutinin glycoprotein in the virus’ pathogenesis.
3. Vaccine development – The ability to specifically target the Hemagglutinin glycoprotein makes our antibody a valuable tool for evaluating the efficacy of CDV vaccines.
Our Anti-CDV H/Hemagglutinin glycoprotein Polyclonal Antibody has been successfully used in various experimental settings, including:
1. Immunofluorescence – The antibody’s high specificity and sensitivity make it an excellent choice for visualizing CDV in infected cells.
2. ELISA – Our antibody has been validated for use in ELISA assays, providing a reliable method for detecting and quantifying CDV.
3. Western blot – The antibody’s strong binding affinity allows for precise detection of the Hemagglutinin glycoprotein in CDV samples.
In summary, our Anti-CDV H/Hemagglutinin glycoprotein Polyclonal Antibody is a valuable tool for studying CDV and its pathogenesis. With its superior binding affinity and sensitivity, it is a must-have for any biotech researcher studying this highly contagious virus. Order now and take your research to the next level!
ProteoGenix catalogue number ARO-A22533. For research use only.
Target: H, Hemagglutinin glycoprotein; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| H, Hemagglutinin glycoprotein |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
